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evere Symptomatic Tricuspid Valve
egurgitation Due to Permanent Pacemaker
r Implantable Cardioverter-Defibrillator Leads
race Lin, MD,* Rick A. Nishimura, MD, FACC,* Heidi M. Connolly, MD, FACC,*
oseph A. Dearani, MD,† Thoralf M. Sundt III, MD,† David L. Hayes, MD, FACC*
ochester, Minnesota
OBJECTIVES We report a series of patients with severe tricuspid valve regurgitation due to a permanent
pacemaker (PPM) or implantable cardioverter-defibrillator (ICD) lead.
BACKGROUND Severe tricuspid regurgitation caused by a PPM or ICD lead is an under-recognized but
treatable etiology of severe right heart failure.
METHODS We reviewed the records of 41 patients who underwent tricuspid valve operation for severe
tricuspid regurgitation caused by previously placed PPM or ICD leads.
RESULTS During surgery, severe tricuspid regurgitation was found to be caused by the PPM or ICD
leads in all 41 patients. There was a perforation of the tricuspid valve leaflet by the PPM or
ICD lead in 7 patients, lead entanglement in the tricuspid valve occurred in 4 patients, lead
impingement of the tricuspid valve leaflets occurred in 16 patients, and lead adherence to the
tricuspid valve occurred in 14 patients. The septal leaflet was most often perforated (6 of 7).
In the preoperative evaluation, valve malfunction due to the PPM or ICD lead was diagnosed
preoperatively in only 5 of 41 (12%) patients by transthoracic echocardiography. All patients
underwent successful tricuspid valve operation (22 tricuspid valve replacement), with one
perioperative death occurring. During follow-up (range, 1 to 99 months), there was one
patient who died from left-sided heart failure and three patients died of other causes. The
remaining patients showed improvement in signs and symptoms of heart failure.
CONCLUSIONS Damage to the tricuspid valve by PPM or ICD leads may result in severe symptomatic
tricuspid regurgitation and may not be overtly visualized by echocardiography. This etiology
should be considered when evaluating patients with severe right heart failure after PPM or
ICD implantation. (J Am Coll Cardiol 2005;45:1672–5) © 2005 by the American College
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.02.037of Cardiology Foundation
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aatients who present with severe right heart failure out of
roportion to left-sided heart disease present a diagnostic
hallenge because the etiology may be due to constrictive
ericarditis, restrictive cardiomyopathy, or pulmonary vas-
ular disease (1–5). We recently have observed the occur-
ence of right heart failure due to tricuspid regurgitation
esulting from a permanent pacemaker (PPM) and implant-
ble cardioverter-defibrillator (ICD) leads, entities that have
ot been well recognized. We report on a series of patients
ho underwent surgical intervention for severe tricuspid
egurgitation proven to be due to PPM or ICD leads, as this
s a correctable cause of right heart failure.
ETHODS
e identified 41 patients who had severe tricuspid regur-
itation caused by a PPM or ICD lead and underwent
peration to repair or replace the malfunctioning tricuspid
alve. Using a Mayo Institutional Review Board-approved
From the *Division of Cardiovascular Disease and the †Division of Cardiovascular
urgery, Mayo Clinic, Rochester, Minnesota. Dr. Hayes’ industry disclosures include
edtronic (sponsored research, speaker, public stockholder), Guidant (sponsored
esearch, speaker, public stockholder, advisory board), and St. Jude (speaker).p
Manuscript received July 28, 2004; revised manuscript received December 24,
004, accepted February 1, 2005.rotocol, we reviewed the records of 1,465 consecutive
atients with severe tricuspid regurgitation who had tricus-
id valve operation between January 1, 1993, and December
1, 2003. One hundred fifty-six of these patients had
reviously placed endocardial PPM or ICD leads. On the
asis of operative findings, we identified 64 patients in
hom the tricuspid regurgitation was due to the previously
mplanted PPM or ICD lead. To rule out other confound-
ng causes for the tricuspid regurgitation, we excluded
atients who had a morphologic abnormality of the tricus-
id valve (previous history of cardiac trauma, [n  2],
acterial endocarditis [n  5], previous tricuspid valve
urgery [n  2], or congenital heart disease [n  14]).
Thus, 41 patients comprised the study population. These
atients all had severe tricuspid regurgitation and a mor-
hologically normal tricuspid valve apparatus with evidence
f tricuspid valve leaflet damage by the PPM or ICD leads
t the time of operation. Forty patients underwent surgery at
he Mayo Clinic; one patient had an evaluation and diag-
osis made at the Mayo Clinic but tricuspid valve surgery
as performed at another institution. Survival and
ollow-up information was obtained from the clinical record
t the Mayo Clinic or from a questionnaire mailed to all
atients.
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May 17, 2005:1672–5 Pacemaker Lead-Related Tricuspid RegurgitationAll 41 patients had preoperative transthoracic echocardiog-
aphy performed at the Mayo Clinic, 13 patients had preop-
rative transesophageal echocardiography, and 38 had intraop-
rative transesophageal echocardiography. The reports from
he preoperative and intraoperative echocardiograms were re-
iewed in all cases; all available echocardiographic images were
ndependently reviewed by two of the authors (G.L. and
.M.C.). All available preoperative chest X-rays (n 38) were
eviewed by two of the authors (G.L. and D.L.H.) to deter-
ine PPM or ICD lead position before surgery. Eight patients
ad their PPM or ICD placed at the Mayo Clinic, and all
ther patients had their devices placed at other institutions.
ESULTS
linical presentation. Baseline clinical characteristics of the
1 patients are shown in Table 1. The mean age of the patients
as 70  10 years, and there were 20 men and 21 women.
here were 21 patients who presented primarily with severe
ight heart failure, including a referral diagnosis of constrictive
ericarditis or restrictive cardiomyopathy in three patients. The
ther 20 patients subsequently were found to have severe
ricuspid regurgitation in addition to other abnormalities, such
s prosthetic valve malfunction, mitral or aortic valve disease, or
ypertrophic obstructive cardiomyopathy. All patients had
evere New York Heart Association functional class III or IV
ymptoms upon presentation.
reviously placed pacemaker or ICD. There were 35
atients who had PPM leads and 6 patients who had ICD
eads that caused the severe tricuspid regurgitation. The
verage time from PPM or ICD placement to surgery was
2 months (i.e., 6 years) with a range of 2 months to 19
ears. Six patients had had subsequent revisions of their
PM systems, including placement of additional ventricular
eads or upgrades to an ICD or biventricular pacemaker.
Abbreviations and Acronyms
ICD  implantable cardioverter-defibrillator
PPM  permanent pacemaker
able 1. Baseline Characteristics
Mean
Total
(Patient Number)
ge (yrs) 70  10 41
en 20
jection fraction (%) 54  14 41
heumatic heart disease 14
oronary artery disease* 16
revious valve surgery 16
Aortic 7
Mitral 9
Both 3
ricuspid annular dilation 15
PM placement, time from
placement to operation (months)
72 (2–228)Previous coronary artery bypass grafting or percutaneous intervention.
PPM  permanent pacemaker.haracteristics of the PPM and ICD lead systems were
nown in 30 patients (37 leads) and are listed in Table 2.
our patients had multiple leads. Of the seven patients who
ad tricuspid valve leaflet perforation, two had multiple (i.e.,
wo or three) leads.
chocardiographic findings. Transthoracic echocardiog-
aphy was performed preoperatively in all 41 patients. The
ean ejection fraction of the left ventricle was 54%. The
ean pulmonary artery systolic pressure derived from
oppler echocardiography was 48 mm Hg (range, 28 to 84
m Hg). There were only 5 of 41 (12%) of patients in
hom tricuspid valve leaflet perforation or impingement by
he PPM or ICD lead was detected on the initial transtho-
acic echocardiography interpretation. Although all patients
ventually were found to have severe tricuspid regurgitation,
nly 26 of 41 (63%) of these patients were diagnosed as
aving severe tricuspid regurgitation on the initial interpre-
ation of the transthoracic echocardiography. Transesopha-
eal echocardiography was performed either preoperatively
r postoperatively in 38 patients. Valve malfunction due to
he PPM lead was observed in 17 of 38 (45%) patients by
ransesophageal echocardiography. Transesophageal echo-
ardiography was able to diagnose severe tricuspid regurgi-
ation in all 38 patients studied.
perative methods and results. All patients were found to
ave morphologically normal tricuspid valve with malfunc-
ion of the valve caused by the PPM or ICD lead at the time
f operation (Table 3). Tricuspid valve perforation by the
able 2. Device Lead Characteristics
ead type
PPM 40
ICD 6
ead insulation*
Silicone 34
Polyurethane 12
rench size*
11 3
9 30
8 2
7 5
6 5
ctive fixation 23
entricular lead (multiple) 6
Data from 46 leads in 36 patients.
ICD  implantable cardiovertor-defibrillator; PPM  permanent pacemaker.
able 3. Operative Findings
perative findings: mechanism of tricuspid regurgitation
Lead adherence 14
Lead entanglement 4
Lead perforation 7
Lead impingement 16
perative procedure
Tricuspid valve replacement
Mechanical 5
Bioprosthesis 17
Annuloplasty
Pursestring 7
Ringed 12
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Pacemaker Lead-Related Tricuspid Regurgitation May 17, 2005:1672–5PM or ICD lead occurred in seven patients, lead entan-
lement of the tricuspid valve apparatus occurred in four
atients, lead impingement of the tricuspid valve leaflets
ccurred in 16 patients, and lead adherence to the tricuspid
alve occurred in 14 patients. Fourteen patients had involve-
ent of the posterior leaflet. When the leaflet was perfo-
ated, the septal leaflet was most often involved (6 of 7
atients). Secondary annular dilatation was noted in 15
atients.
Nineteen patients had an isolated tricuspid valve opera-
ion. Twenty-two patients required surgical intervention on
ther valves at the time of surgery, and 15 patients had other
urgical interventions, including pericardiectomy and myec-
omy. The surgical approach to the tricuspid valve at
peration varied according to individual surgeon prefer-
nces. In the absence of extensive tricuspid valve leaflet
amage, valve repair was preferred. When valve repair was
easible, it consisted of: 1) removing or displacing the lead
way from the affected leaflet; 2) suture repair of a defect in
he leaflet; or 3) positioning the PPM lead by suture fixation
n recess of either the posteroseptal or anteroposterior
ommissure. Intraoperative echocardiography was used to
ssure that the tricuspid regurgitation was reduced after
ricuspid valve repair. Tricuspid annular dilatation was
reated by either a DeVega purse string or ringed annulo-
lasty. When tricuspid repair was not possible because of
amage to the leaflet by the PM or ICD lead, valve
eplacement was performed (22 patients). Tricuspid valve
eplacement was performed by maintaining the native tri-
uspid valve intact and positioning the pacing lead external
o the sewing ring of the prosthesis. There was one
erioperative death (operative mortality 2.4%).
ollow-up. Patient follow-up ranged from 1 to 99 months
mean, 8.2 years). Seven patients were lost to follow-up, and
wo declined to answer the questionnaire. There were four
eaths, one due to left heart failure and three of unknown
auses. No patient required additional surgery or lead
evisions. The remaining patients all noted improvement in
ymptoms of their right heart failure.
ISCUSSION
his series is the first reporting on patients with severe
ymptomatic tricuspid regurgitation due to PPM or ICD
able 4. Reported Cases of Tricuspid Valve Leaflet Perforation b
No. of
Cases
Found at Autopsy
or Surgery
Tricuspi
Valve
Leaflet
ould et al. (12) 1 Autopsy Anterio
ecker et al. (16) 1 Autopsy Posterio
echt et al. (15) 1 Autopsy Posterio
etterson et al. (14) 1 Autopsy Anterio
hristie and Keelan (13) 1 Autopsy Septal
hampagne et al. (17) 1 Surgery Posterio
ubio and Al-Basram (18) 1 Surgery PosterioHF  congestive heart failure; PPM  permanent pacemaker.eads requiring tricuspid valve surgery. Isolated case reports
ave been noted of entrapment of a PPM lead in the
ricuspid apparatus during implantation, resulting in avul-
ion or laceration of the tricuspid valve leaflets upon removal
f the PPM lead (6–11) and case reports of perforation of
tricuspid valve leaflet by a PPM (Table 4) (12–18).
chocardiographic detection of tricuspid regurgitation in
atients with a PPM has been reported (19). However, the
ccurrence of severe symptomatic tricuspid regurgitation
ue to damage from PPM or ICD leads is not a well-
ecognized entity.
The mechanism by which a PPM or ICD lead causes
ricuspid regurgitation has not been previously evaluated.
utopsy reports have indicated that PPM leads can cause
brosis and subsequent adherence to the tricuspid valve
eaflets as early as 17 days after implantation (16,20–22).
As shown in this study, the mechanism of tricuspid
egurgitation due to PPM or ICD leads is variable. The
argest subset of patients in our study (n 16) had only lead
mpingement on the tricuspid valve leaflets at surgery.
ther mechanisms include leaflet perforation, entanglement
f the tricuspid valve apparatus, and adhesion of the PPM
r ICD to the tricuspid valve leaflet.
It is necessary to have a high clinical index of suspicion
or this particular disease entity. Elevated venous pressure
ith large “V” waves upon physical examination is an
mportant clue to the diagnosis, and one cannot rely on a
outine echocardiogram to provide the diagnosis. Even in
xperienced echocardiographic laboratories, the detection of
evere tricuspid regurgitation may be missed because of
coustic shadowing from the pacemaker wires and subopti-
al visualization of the regurgitant jet. In addition, direct
isualization of the mechanism of the PPM or ICD lead
ausing severe regurgitation was identified in only 12% of
atients with routine transthoracic echocardiography. With
high index of suspicion, further diagnostic information
ould be obtained from goal-directed imaging by transtho-
acic or transesophageal echocardiography. On a retrospec-
ive independent review of the images of the transthoracic
chocardiogram, there were 22% of patients in whom the
PM or ICD lead was identified as a cause of the tricuspid
egurgitation. Transesophageal echocardiography was able
o visualize the PPM or ICD lead as a cause of tricuspid
PM Lead (12–18)
Clinical
Presentation
Time from PPM Implantation
to Presentation Insulation
CHF 4 months Unknown
PPM failure 6 months Unknown
PPM failure 9 months Unknown
Bradycardia 1 year Silicone
CHF 2 years Polyurethane tined
CHF 9 years Polyurethane tined
CHF 10 years Unknowny a P
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May 17, 2005:1672–5 Pacemaker Lead-Related Tricuspid Regurgitationegurgitation in 45% of patients. In the future, three-
imensional echocardiographic imaging may be helpful to
ore clearly delineate the location of the PPM or ICD leads
nd the impact on the tricuspid valve. Also, patients may
ot develop symptoms of right heart failure for years after
PM implantation, as shown in this study herein.
We were unable to determine a relationship between lead
haracteristics and the likelihood of PPM or ICD lead
amage to the tricuspid valve as a result of the small number
f patients in this study. The increased number of silicone-
nsulated leads, larger French sizes, and number of passive
xation leads may simply reflect the characteristics of older
eads identified in this retrospective study. There are limited
ublished data regarding the physical characteristics of the
PM leads identified in the cases of perforations we
eviewed or in autopsy series describing PPM lead adhesion
o the tricuspid valve leaflets (12,14–18,20–23).
Although previous series have suggested that having
ultiple PPM leads across the tricuspid valve may increase
chocardiographic findings of tricuspid regurgitation when
ompared with patients with single leads (24,25), we could
ot determine whether this relationship was present because
f the small number of patients in this series.
The number of cases of severe tricuspid regurgitation due
o PPM or ICD leads is probably larger than identified in
ur series. There has been an increase in the number of
ricuspid valve operations to correct tricuspid regurgitation
elated to PPM lead-related injury performed at our insti-
ution in the last few years. From 1993 to 2001, only one to
hree cases occurred each year, but in 2002 and 2003 we
oted 11 and 16 cases, respectively. Thirteen of 27 of the
perations performed in 2002 and 2003 were referred
rimarily for tricuspid valve surgery. We believe this reflects
n increasing awareness of this clinical problem rather than
true higher incidence.
tudy limitations. This was a retrospective analysis of
atients undergoing operation for severe tricuspid regurgi-
ation due to PPM or ICD leads, and we were unable to
ddress the incidence of this complication. We did not
xclude patients with left-sided valvular disease, ischemic
eart disease, or known rheumatic heart disease. Thus,
econdary pulmonary hypertension may have contributed to
urther increase the severity of tricuspid regurgitation. We
annot rule out the possibility that dyssynchronous contrac-
ion caused by right ventricular apical pacing could have
ontributed to the severity of tricuspid regurgitation. How-
ver, in all patients at the time of operation, the surgeon
dentified the PPM or ICD lead as the primary cause of
ricuspid regurgitation.
Our findings suggest that PPM or ICD lead-related
njury to the tricuspid valve can result in clinically important
evere tricuspid regurgitation and secondary right heart
ailure. These patients have symptomatic improvement after
ricuspid valve repair or replacement. The diagnosis of
ricuspid valve injury can be difficult by echocardiography
nd, thus, a high index of clinical suspicion must be presenthen patients present with severe right heart failure after
PM or ICD implantation.
eprint requests and correspondence: Dr. Rick A. Nishimura,
ayo Clinic, Gonda 5-468 East, 200 First Street SW, Rochester,
innesota 55905. E-mail: nishimura.rick@mayo.edu.
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